Jamie Dimon provides some great insights in his Annual Shareholder Letters at JPMorgan Chase. In his latest letter Dimon makes a great point regarding the non-linear nature of companies and markets. Here’s an excerpt from that letter: Volatility and rapidly moving markets should surprise no one. We are always prepared … Read More
This Week’s Best Investing Reads 06/08/2018
Here is a list of this week’s best investing reads: Experience is Overrated (A Wealth of Common Sense) The Next Fifty Years (The Irrelevant Investor) The Psychology of Money (Collaborative Fund) The Economy is on Fire (The Reformed Broker) Bitcoin, Blockchain, and Money (csinvesting) To Succeed at Value Investing, You Need to Change (GuruFocus) ‘For investors, the danger is already … Read More
Forbes: Is Value Investing For Losers? No, So Don’t Get Tricked
Here’s a recent article at Forbes that discusses the cyclical nature of value investing and the importance of sticking with a value strategy during periods of underperformance, like the most recent one, saying: “This cycle is deep into the “growth dominates” phase, but the last thing you should do is … Read More
Jason Zweig: How Companies Use the Latest Profits Fad to Fool You
Here’s a great article by Jason Zweig at the WSJ which discusses how companies use the latest profits fad to fool investors: Eighty-six years ago this week, the stock market hit its worst low. Today, with markets near all-time highs, things aren’t as different as you might think. Then, as … Read More
Why A Do-Nothing Approach To Investing Is Often The Right Way To Go
Here’s a great article at The Globe And Mail which illustrates how investors are hurting their returns by actively over trading in stocks saying: “Trading is clearly the enemy of superior returns on a before-tax basis. This is doubly true in the after-tax world in which we all live.” Here’s … Read More
Acquirer’s Multiple Stocks Appearing in Dalio, Greenblatt, Simons Portfolios
One of the new weekly additions here at The Acquirer’s Multiple features some of the top picks from our Stock Screeners and some top investors who are holding these same picks in their portfolios. Investors such as Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, Seth Klarman, Ray Dalio, and … Read More
Philip Carret: All Stock Investors Are Speculators By Necessity
One of the best books written on investing is The Art Of Speculation, by Philip Carret. There’s one passage in particular in which Carret illustrates how all stock investors are speculators by necessity. Here’s an excerpt from that book: It is unfortunate that the word “speculation” immediately suggests the word … Read More
Mohnish Pabrai: “We can do really well in the business even if we don’t understand 98% of the markets and the companies in them”
Here’s a great recent interview with Mohnish Pabrai and the folks at ET. During the interview Pabrai provided a number of valuable insights on his value investing approach. Here are some excerpts from that interview: High-uncertainty businesses coupled with low-risk result in high returns… Pabrai: It’s very interesting because stock … Read More
Ray Dalio: “Think About How To Rotate Your Portfolio To Buy That Which Is Cheap And Sell That Which Is Expensive”
Last week Ray Dalio did a question and answer session with some folks on Reddit where he shared a number of valuable investing insights. Dalio started the conversation with the following message: “I’m Ray Dalio—founder of Bridgewater Associates and author of Principles. This is my first AMA. Ask me anything!” My … Read More
This Week’s Best Investing Reads 06/01/2018
Here is a list of this week’s best investing reads: 3 Misconceptions About Interest Rates (A Wealth of Common Sense) Never Begin With the End in Mind (The Irrelevant Investor) Combatting F.O.M.B.E.Y. (The Reformed Broker) What’s Behind The Rapid Plunge In The ‘Smart Money Index’? (The Felder Report) Banks Won Big in Washington. What It Means for Investors (Jason Zweig) … Read More
AM Stock Screener – Undervalued United Therapeutics Corporation (NASDAQ: UTHR)
One of the cheapest stocks in our All Investable Stock Screener is United Therapeutics Corporation (NASDAQ: UTHR). United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The firm is a market leader in two … Read More
Acquirer’s Multiple Stocks Appearing in Superinvestor Portfolios
One of the new weekly additions here at The Acquirer’s Multiple features some of the top picks from our Stock Screeners and some top investors who are holding these same picks in their portfolios. Investors such as Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, Seth Klarman, Ray Dalio, and … Read More
James Montier: You Can Turn Behavioral Biases Into An Advantage Using A Valuation-Based Framework
We’ve just been listening to a great interview with James Montier on Meb Faber’s podcast. During the interview Montier provides some great insights to help investors protect themselves from their behavioral biases. Montier says that you can actually turn behavioral biases, like anchoring, into an advantage using a valuation-based framework. … Read More
Ed Thorp: The Importance Of Having An Edge In Investing
Here’s some great investing insights from Ed Thorp, author of Beat the Dealer and A Man for All Markets, from his interview with Jack Schwager in his book – Hedge Fund Market Wizards. During the interview, Thorp explained the importance of having an edge in investing and matching your skill set … Read More
Prem Watsa: If You Get Two Out Of Three Right, You Will Have One Of The Best Track Records
Here’s a great recent interview with Prem Watsa discussing investing with Bloomberg’s Amanda Lang on “What’d You Miss?”. During the interview Watsa shares some great insights on what makes a great investor. Here’s an excerpt from that interview: Amanda Lang: Have there been investments that you regret? Prem Watsa: Oh! I … Read More
Seth Klarman Protege David Abrams Says “Value Investing Is The E = mc² Of Money And Investing”
One of our favorite investors to follow here at The Acquirer’s Multiple is Seth Klarman’s protege David Abrams. Abrams typically shuns the public limelight so it’s difficult to find interviews where he shares his investing strategy. The WSJ did a great story on him back in 2014 titled – Hedge-Fund World’s … Read More
This Week’s Best Investing Reads 05/25/2018
Here is a list of this week’s best investing reads: The Pygmalion Effect: Proving Them Right (Farnam Street) Stocks prices are a proxy for our beliefs about the future (The Reformed Broker) Condemned to Repeat the Mistakes of the Past (csinvesting) On Second Thought… (The Irrelevant Investor) To Be A New Fool In The World (Jason Zweig) Thinking Outside … Read More
Acquirer’s Multiple Stocks Appearing in Icahn, Dalio, Greenblatt Portfolios
One of the new weekly additions here at The Acquirer’s Multiple features some of the top picks from our Stock Screeners and some top investors who are holding these same picks in their portfolios. Investors such as Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, Seth Klarman, Ray Dalio, and … Read More
Nassim Taleb: How Frequent The Profit Is Irrelevant; It Is The Magnitude Of The Outcome That Counts
Here’s a great investing lesson by Nassim Taleb from his book Fooled by Randomness. Similarly to Michael Mauboussin in this article, Taleb makes the point that it’s not how frequently you profit from your investments that important, it’s the magnitude of the outcome that counts. Here’s an excerpt from the book: … Read More
Michael Mauboussin: The Babe Ruth Effect Generates More Successful Returns
Here’s a great lesson from Michael Mauboussin’s book – More Than You Know. Mauboussin highlights the point that when it comes to successful investing it’s not about the frequency of correctness that matters in stock picking, it’s the magnitude of correctness that matters. This is called the Babe Ruth Effect. Here’s an excerpt from … Read More